Kestra Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$700K Sell
8,947
-21,828
-71% -$1.76M 0.01% 279
2026
Q1
$2.67M Sell
30,775
-9,644
-24% -$924K 0.05% 107
2025
Q4
$3.88M Buy
40,419
+2,874
+8% +$279K 0.1% 81
2025
Q3
$3.6M Buy
37,545
+4,781
+15% +$440K 0.1% 84
2025
Q2
$2.86M Buy
32,764
+9,525
+41% +$808K 0.09% 86
2025
Q1
$2.09M Buy
23,239
+16,575
+249% +$1.48M 0.07% 92
2024
Q4
$532K Buy
6,664
+705
+12% +$61K 0.02% 217
2024
Q3
$536K Buy
+5,959
New +$501K 0.02% 203

Other funds holding MDT

Kestra Investment Management's MDT Position: Q2 2026 in Review

Kestra Investment Management reduced its Medtronic (MDT) stake by 71% in Q2 2026, selling an estimated $1.76M and leaving 8,947 shares worth $700K. The position accounts for 0.01% of the portfolio, ranked #279.

Kestra Investment Management first reported a position in MDT in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.88M in Q4 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Kestra Investment Management held 8,947 shares of Medtronic worth $700K as of Q2 2026.
  • Kestra Investment Management sold 21,828 Medtronic shares in Q2 2026, an estimated $1.76M.
  • Medtronic made up 0.01% of Kestra Investment Management's portfolio in Q2 2026, its #279 holding.
  • Kestra Investment Management first reported a position in Medtronic in Q3 2024 and has held it in 8 quarters since.
  • Kestra Investment Management's Medtronic position peaked at $3.88M in Q4 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Kestra Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.